Abivax S.A. (ABVX) Financials

ABVX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 527.5 million 109.5 million
March 31, 2026 627.0 million 134.7 million
Dec. 31, 2025 765.5 million 165.3 million
Sept. 30, 2025 765.2 million 165.2 million

ABVX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -59.5 million 19.2 million
March 31, 2026 -58.0 million 25.9 million
Dec. 31, 2025 -83.7 million -12.9 million
Sept. 30, 2025 -83.6 million 13.5 million

ABVX Net Income

No data available :(

ABVX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 468.7 million - 1.4 million
March 31, 2026 - - 1.7 million
Dec. 31, 2025 622.4 million 18.6 million 1.8 million
Sept. 30, 2025 - - 1.8 million

ABVX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 90.9 million
March 31, 2026 90.9 million
Dec. 31, 2025 81.6 million
Sept. 30, 2025 91.3 million

ABVX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 127823 66.6 million 30.8 million 116410
March 31, 2026 61881 56.8 million 9.2 million -
Dec. 31, 2025 9391 52.1 million 32.5 million 16435
Sept. 30, 2025 - 65.0 million 32.1 million -

ABVX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 -2.4 million 1.2 million
Sept. 30, 2025 - -

ABVX

Price: $86.94

52 week price:
69.81
148.83

Earnings Per Share: -6.11 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 6.4 billion

Links: